Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.22 → 1.22 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for FTLF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage competitive pressures in online sales channels | A supporting condition in FitLife Brands, Inc.'s published investment case. The stated target is stabilize or improve online sales performance. | Improving | online sales decline or market share loss worsens materially | Q1 rev +59% vs stabilize target Q1 revenue up 59%; online sales faced challenges but overall growth and new product pipeline reinforce positive trend. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
FTLF is a high-risk growth story with some cyclical exposure, rather than a proven durable compounder. Its long-term thesis is on watch: recent results show progress, but performance remains below its industry cohort.
The evidence describes FTLF as cheap versus peers, while also tagging expectations as stretched. Valuation has risen recently, and the expectations gap suggests the market may already assume some continued progress.
Near term, revenue has grown strongly year over year, and the latest quarter showed higher adjusted EBITDA than a year earlier. Management continues to emphasize revenue growth and a first-full-year EBITDA goal, but delivery is still partial; a guidance cut or weakening jobs data would add risk.
The multi-year thesis hinges on whether revenue growth turns into sustained operating improvement and progress toward management’s EBITDA goal. Near term, guidance and jobs data are key risks, while continued strength among sector bellwethers could support the sector backdrop.
FTLF has encouraging growth evidence, but high risk, stretched expectations, and below-cohort performance leave the 1-to-3-year thesis unsettled. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Improve operating income to at least $3.1 million quarterly |
| Operating income rose from $2.5 million to $3.1 million in the same period. |
| Intact |
| operating income falls below $3.1 million in any quarter |
Operating income: $3.355M FY2026-Q2; GAAP. Published target: >= $3.1 million operating income per quarter. Target period is not explicitly aligned with this observation. Aug 13, 20263,355,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain revenue growth near or above 17% annually | A primary condition in FitLife Brands, Inc.'s published investment case. The stated target is >=17% YoY revenue growth. | Intact | YoY revenue growth falls below 17% in FY26 | Revenue growth: 64.62% FY2026-Q2; GAAP. Published target: >=17% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 202664.624543 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.10 → $1.22 · observed estimates
$0.11B → $0.11B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-25 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-26 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-27 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-28 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-29 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-07-30 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-07-31 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-01 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-02 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-03 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-04 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-05 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-06 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-07 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-08 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-09 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-10 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-12 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-13 | $1.10 | $113,370,500 | 2 / 2 |
| 2026-08-14 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-15 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-16 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-17 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-18 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-19 | $1.10 | $113,362,500 | 1 / 1 |
| 2026-08-20 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-21 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-22 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-23 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-24 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-25 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-26 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-27 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-28 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-29 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-30 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-08-31 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-01 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-02 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-03 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-04 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-05 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-06 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-07 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-08 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-09 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-10 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-11 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-12 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-13 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-14 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-15 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-16 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-17 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-18 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-19 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-20 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-21 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-22 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-23 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-24 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-25 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-26 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-27 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-28 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-29 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-09-30 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-01 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-02 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-03 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-04 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-05 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-06 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-07 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-08 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-09 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-10 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-11 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-12 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-13 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-14 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-15 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-16 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-17 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-18 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-19 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-20 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-21 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-22 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-23 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-24 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-25 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-26 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-27 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-28 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-29 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-30 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-10-31 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-11-01 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-11-02 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-11-03 | $1.22 | $112,619,500 | 1 / 1 |
| 2026-11-04 | $1.22 | $112,619,500 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.